114 related articles for article (PubMed ID: 30463058)
1. Development of Inflammatory Immune Response-Related Drugs Based on G Protein-Coupled Receptor Kinase 2.
Han C; Li Y; Wang Y; Cui D; Luo T; Zhang Y; Ma Y; Wei W
Cell Physiol Biochem; 2018; 51(2):729-745. PubMed ID: 30463058
[TBL] [Abstract][Full Text] [Related]
2. G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives.
Guccione M; Ettari R; Taliani S; Da Settimo F; Zappalà M; Grasso S
J Med Chem; 2016 Oct; 59(20):9277-9294. PubMed ID: 27362616
[TBL] [Abstract][Full Text] [Related]
3. Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels.
Taguchi K; Sakata K; Ohashi W; Imaizumi T; Imura J; Hattori Y
J Pharmacol Exp Ther; 2014 May; 349(2):199-208. PubMed ID: 24570070
[TBL] [Abstract][Full Text] [Related]
4. Small-Molecule G Protein-Coupled Receptor Kinase Inhibitors Attenuate G Protein-Coupled Receptor Kinase 2-Mediated Desensitization of Vasoconstrictor-Induced Arterial Contractions.
Rainbow RD; Brennan S; Jackson R; Beech AJ; Bengreed A; Waldschmidt HV; Tesmer JJG; Challiss RAJ; Willets JM
Mol Pharmacol; 2018 Sep; 94(3):1079-1091. PubMed ID: 29980659
[TBL] [Abstract][Full Text] [Related]
5. Design of substrates and inhibitors of G protein-coupled receptor kinase 2 (GRK2) based on its phosphorylation reaction.
Kang JH; Toita R; Kawano T; Murata M; Asai D
Amino Acids; 2020 Jul; 52(6-7):863-870. PubMed ID: 32577910
[TBL] [Abstract][Full Text] [Related]
6. Antidiabetic and Cardioprotective Effects of Pharmacological Inhibition of GRK2 in db/db Mice.
Cipolletta E; Gambardella J; Fiordelisi A; Del Giudice C; Di Vaia E; Ciccarelli M; Sala M; Campiglia P; Coscioni E; Trimarco B; Sorriento D; Iaccarino G
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934608
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors.
Carotenuto A; Cipolletta E; Gomez-Monterrey I; Sala M; Vernieri E; Limatola A; Bertamino A; Musella S; Sorriento D; Grieco P; Trimarco B; Novellino E; Iaccarino G; Campiglia P
Eur J Med Chem; 2013 Nov; 69():384-92. PubMed ID: 24077529
[TBL] [Abstract][Full Text] [Related]
8. GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.
Cannavo A; Koch WJ
Cell Signal; 2018 Jan; 41():33-40. PubMed ID: 28077324
[TBL] [Abstract][Full Text] [Related]
9. Identification of inhibitors of the RGS homology domain of GRK2 by docking-based virtual screening.
Echeverría E; Velez Rueda AJ; Cabrera M; Juritz E; Burghi V; Fabián L; Davio C; Lorenzano Menna P; Fernández NC
Life Sci; 2019 Dec; 239():116872. PubMed ID: 31525427
[TBL] [Abstract][Full Text] [Related]
10. G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis.
Mayor F; Cruces-Sande M; Arcones AC; Vila-Bedmar R; Briones AM; Salaices M; Murga C
Cell Signal; 2018 Jan; 41():25-32. PubMed ID: 28389415
[TBL] [Abstract][Full Text] [Related]
11. Regulatory effects of GRK2 on GPCRs and non-GPCRs and possible use as a drug target (Review).
Han CC; Ma Y; Li Y; Wang Y; Wei W
Int J Mol Med; 2016 Oct; 38(4):987-94. PubMed ID: 27573285
[TBL] [Abstract][Full Text] [Related]
12. Paeoniflorin inhibits proliferation of fibroblast-like synoviocytes through suppressing G-protein-coupled receptor kinase 2.
Chen JY; Wu HX; Chen Y; Zhang LL; Wang QT; Sun WY; Wei W
Planta Med; 2012 May; 78(7):665-71. PubMed ID: 22411721
[TBL] [Abstract][Full Text] [Related]
13. G protein-coupled receptor kinase 2 (GRK2) in migration and inflammation.
Penela P; Murga C; Ribas C; Salcedo A; Jurado-Pueyo M; Rivas V; Aymerich I; Mayor F
Arch Physiol Biochem; 2008 Jul; 114(3):195-200. PubMed ID: 18618354
[TBL] [Abstract][Full Text] [Related]
14. Novel inhibitors of phosphorylation independent activity of GRK2 modulate cAMP signaling.
Echeverría E; Ripoll S; Fabián L; Shayo C; Monczor F; Fernández NC
Pharmacol Res Perspect; 2022 Apr; 10(2):e00913. PubMed ID: 35184416
[TBL] [Abstract][Full Text] [Related]
15. Sustaining Circulating Regulatory T Cell Subset Contributes to the Therapeutic Effect of Paroxetine on Mice With Diabetic Cardiomyopathy.
Han Y; Lai J; Tao J; Tai Y; Zhou W; Guo P; Wang Z; Wang M; Wang Q
Circ J; 2020 Aug; 84(9):1587-1598. PubMed ID: 32741881
[TBL] [Abstract][Full Text] [Related]
16. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets.
Penela P; Murga C; Ribas C; Lafarga V; Mayor F
Br J Pharmacol; 2010 Jun; 160(4):821-32. PubMed ID: 20590581
[TBL] [Abstract][Full Text] [Related]
17. Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy.
Sorriento D; Santulli G; Franco A; Cipolletta E; Napolitano L; Gambardella J; Gomez-Monterrey I; Campiglia P; Trimarco B; Iaccarino G; Ciccarelli M
J Cardiovasc Transl Res; 2015 Nov; 8(8):493-502. PubMed ID: 26224342
[TBL] [Abstract][Full Text] [Related]
18. Canonical and Non-Canonical Roles of GRK2 in Lymphocytes.
Cheng J; Lucas PC; McAllister-Lucas LM
Cells; 2021 Feb; 10(2):. PubMed ID: 33546162
[TBL] [Abstract][Full Text] [Related]
19. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy.
Lieu M; Koch WJ
Expert Opin Ther Targets; 2019 Mar; 23(3):201-214. PubMed ID: 30701991
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors.
Thal DM; Yeow RY; Schoenau C; Huber J; Tesmer JJ
Mol Pharmacol; 2011 Aug; 80(2):294-303. PubMed ID: 21596927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
